PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma

International Journal of Oncology

Volumn 40, Issue 6, 2012, Pages 1839-1848

  Onishi, Yasuo ^a   Kawamoto, Teruya ^a   Kishimoto, Kenta ^a   Hara, Hitomi ^a   Fukase, Naomasa ^a   Toda, Mitsunori ^a   Harada, Risa ^a   Kurosaka, Masahiro ^a   Akisue, Toshihiro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Invasion; Metastasis; Migration; Osteosarcoma; PKD1; Proliferation

Indexed keywords

COMPLEMENTARY DNA; GELATINASE A; MESSENGER RNA; PROTEIN KINASE D; PROTEIN KINASE D1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; METASTASIS POTENTIAL; NEURILEMOMA; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEURILEMMOMA; OSTEOSARCOMA; TRPP CATION CHANNELS;

EID: 84861790526     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1400     Document Type: Article

References (50)

1. Meyers PA, Heller G, Healey J, et al: Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 10: 5-15, 1992.
2. Johannes FJ, Prestle J, Dieterich S, Oberhagemann P, Link G and Pfizenmaier K: Characterization of activators and inhibitors of protein kinase C mu. Eur J Biochem 227: 303-307, 1995.
3. Johannes FJ, Prestle J, Eis S, Oberhagemann P and Pfizenmaier K: PKCu is a novel, atypical member of the protein kinase C family. J Biol Chem 269: 6140-6148, 1994. (Pubitemid 24243002)
4. Lavalle CR, George KM, Sharlow ER, Lazo JS, Wipf P and Wang QJ: Protein kinase D as a potential new target for cancer therapy. Biochim Biophys Acta 1806: 183-192, 2010.
5. Van Lint J, Rykx A, Maeda Y, et al: Protein kinase D: an intracellular traffic regulator on the move. Trends Cell Biol 12: 193-200, 2002. (Pubitemid 34442242)
6. Bowden ET, Barth M, Thomas D, Glazer RI and Mueller SC: An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 18: 4440-4449, 1999. (Pubitemid 29396652)
7. Rozengurt E, Rey O and Waldron RT: Protein kinase D signaling. J Biol Chem 280: 13205-13208, 2005. (Pubitemid 40517202)
8. Storz P and Toker A: Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway. EMBO J 22: 109-120, 2003. (Pubitemid 36091274)
9. Yang JM, Chin KV and Hait WN: Interaction of P-glycoprotein with protein kinase C in human multidrug resistant carcinoma cells. Cancer Res 56: 3490-3494, 1996.
10. Henttu P and Vihko P: The protein kinase C activator, phorbol ester, elicits disparate functional responses in androgen-sensitive and androgen-independent human prostatic cancer cells. Biochem Biophys Res Commun 244: 167-171, 1998. (Pubitemid 28419918)
11. Jaggi M, Rao PS, Smith DJ, et al: E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer. Cancer Res 65: 483-492, 2005.
12. Song J, Li J, Lulla A, Evers BM and Chung DH: Protein kinase D protects against oxidative stress-induced intestinal epithelial cell injury via Rho/ROK/PKC-delta pathway activation. Am J Physiol Cell Physiol 290: C1469-C1476, 2006. (Pubitemid 43830786)
13. Simpson KJ, Dugan AS and Mercurio AM: Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma. Cancer Res 64: 8694-8701, 2004. (Pubitemid 39552085)
14. Jaggi M, Rao PS, Smith DJ, Hemstreet GP and Balaji KC: Protein kinase C mu is down-regulated in androgen-independent prostate cancer. Biochem Biophys Res Commun 307: 254-260, 2003. (Pubitemid 36818862)
15. Kim M, Jang HR, Kim JH, et al: Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion. Carcinogenesis 29: 629-637, 2008. (Pubitemid 351404881)
16. Eiseler T, Doppler H, Yan IK, Goodison S and Storz P: Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion. Breast Cancer Res 11: R13, 2009.
17. Choong PF: The molecular basis of skeletal metastases. Clin Orthop Relat Res 415 (Suppl): S19-S31, 2003.
18. Hidalgo M and Eckhardt SG: Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 93: 178-193, 2001. (Pubitemid 32166488)
19. Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174, 2002. (Pubitemid 37328786)
20. Bjornland K, Flatmark K, Pettersen S, Aaasen AO, Fodstad O and Maelandsmo GM: Matrix metalloproteinases participate in osteosarcoma invasion. J Surg Res 127: 151-156, 2005. (Pubitemid 41080627)
21. Hitora T, Yamamoto T, Akisue T, et al: Establishment and characterization of a KIT-positive and stem cell factor-producing cell line, KTHOS, derived from human osteosarcoma. Pathol Int 55: 41-47, 2005. (Pubitemid 40343722)
22. Albini A: Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms. Pathol Oncol Res 4: 230-241, 1998.
23. Liang CC, Park AY and Guan JL: In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2: 329-333, 2007. (Pubitemid 47040047)
24. Okada Y, Akisue T, Hara H, et al: The effect of bevacizumab on tumour growth of malignant fibrous histiocytoma in an animal model. Anticancer Res 30: 3391-3395, 2010.
25. Woodhouse EC, Chuaqui RF and Liotta LA: General mechanisms of metastasis. Cancer 80: 1529-1537, 1997. (Pubitemid 27444024)
26. Fromigue O, Hamidouche Z and Marie PJ: Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion. J Biol Chem 283: 30549-30556, 2008.
27. Jaggi M, Du C, Zhang W and Balaji KC: Protein kinase D1: a protein of emerging translational interest. Front Biosci 12: 3757-3767, 2007.
28. Kikkawa U, Takai Y, Tanaka Y, Miyake R and Nishizuka Y: Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters. J Biol Chem 258: 11442-11445, 1983. (Pubitemid 13019291)
29. Kawamoto T, Akisue T, Kishimoto K, et al: Inhibition of PKCalpha activation in human bone and soft tissue sarcoma cells by the selective PKC inhibitor PKC412. Anticancer Res 28: 825-832, 2008. (Pubitemid 351578926)
30. Fukase N, Kawamoto T, Kishimoto K, et al: Protein kinase Cdelta in tumorigenesis of human malignant fibrous histiocytoma. Oncol Rep 26: 1221-1226, 2011.
31. Kang GH, Kim KM, Park CK and Kang DY: PKC-theta expression in Ewing sarcoma/primitive neuroectodermal tumour and malignant peripheral nerve sheath tumour. Histopathology 55: 368-369, 2009.
32. Tirado OM, MacCarthy CM, Fatima N, Villar J, Mateo-Lozano S and Notario V: Caveolin-1 promotes resistance to chemotherapyinduced apoptosis in Ewing's sarcoma cells by modulating PKCalpha phosphorylation. Int J Cancer 126: 426-436, 2010.
33. Trauzold A, Schmiedel S, Sipos B, et al: PKCmu prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells. Oncogene 22: 8939-8947, 2003. (Pubitemid 38021510)
34. Ristich VL, Bowman PH, Dodd ME and Bollag WB: Protein kinase D distribution in normal human epidermis, basal cell carcinoma and psoriasis. Br J Dermatol 154: 586-593, 2006. (Pubitemid 43374080)
35. Chen J, Deng F, Singh SV and Wang QJ: Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2. Cancer Res 68: 3844-3853, 2008.
36. Forest M: Histologic classification of bone tumors (WHO, 1993). Ann Pathol 15: 226-227, 1995.
37. Wunder JS, Bull SB, Aneliunas V, et al: MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study. J Clin Oncol 18: 2685-2694, 2000. (Pubitemid 30463550)
38. Whelan JS: Osteosarcoma. Eur J Cancer 33: 1611-1619, 1997.
39. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000. (Pubitemid 30046295)
40. Van Noorden CJ: Proteases and protease inhibitors in cancer. Acta Histochem 100: 344-354, 1998.
41. Wu D and Terrian DM: Regulation of caveolin-1 expression and secretion by a protein kinase cepsilon signaling pathway in human prostate cancer cells. J Biol Chem 277: 40449-40455, 2002. (Pubitemid 35215621)
42. Syed V, Mak P, Du C and Balaji KC: Beta-catenin mediates alteration in cell proliferation, motility and invasion of prostate cancer cells by differential expression of E-cadherin and protein kinase D1. J Cell Biochem 104: 82-95, 2008.
43. Biswas MH, Du C, Zhang C, Straubhaar J, Languino LR and Balaji KC: Protein kinase D1 inhibits cell proliferation through matrix metalloproteinase-2 and matrix metalloproteinase-9 secretion in prostate cancer. Cancer Res 70: 2095-2104, 2010.
44. Gupta GP and Massague J: Cancer metastasis: building a framework. Cell 127: 679-695, 2006. (Pubitemid 44781029)
45. Friedl P and Wolf K: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3: 362-374, 2003. (Pubitemid 37328856)
46. Yui Y, Itoh K, Yoshioka K, et al: Mesenchymal mode of migration participates in pulmonary metastasis of mouse osteosarcoma LM8. Clin Exp Metastasis 27: 619-630, 2010.
47. Cowell CF, Yan IK, Eiseler T, Leightner AC, Doppler H and Storz P: Loss of cell-cell contacts induces NF-kappaB via RhoA-mediated activation of protein kinase D1. J Cell Biochem 106: 714-728, 2009.
48. Matsumoto Y, Tanaka K, Harimaya K, Nakatani F, Matsuda S and Iwamoto Y: Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells. Jpn J Cancer Res 92: 429-438, 2001. (Pubitemid 32427780)
49. Enomoto M, Hayakawa S, Itsukushima S, et al: Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling. Oncogene 28: 3197-3208, 2009.
50. Liotta LA and Stetler-Stevenson WG: Metalloproteinases and cancer invasion. Semin Cancer Biol 1: 99-106, 1990.